Synedgen, Inc Email Format
Biotechnology ResearchCalifornia, United States11-50 Employees
Synedgen, Inc. is a biotechnology research company based in Claremont, California, focused on developing medical technologies and therapies that promote healing, reduce tissue damage and inflammation, and prevent infections by drug-resistant bacteria by disrupting the biofilms in which they thrive. The organization emphasizes applying natural principles to address real-time health challenges and translating biological insights into practical solutions. Its platform targets human glycobiology to tackle a range of diseases, including gastrointestinal conditions. The company operates as a small to mid-sized biotechnology organization serving medical and clinical stakeholders focused on infection control, wound care, and inflammatory diseases, with aims to reduce complications and improve patient outcomes. In July 2025, Synedgen announced leadership changes involving Dr. Laura Saward and Dr. Kenton Gregory, signaling an evolution in the company's leadership.